The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival.


BACKGROUND The complement of the cancer mortality to incidence ratio [1-(M/I)] has been suggested as a valid proxy for 5-year relative survival. Whether this suggestion holds true for all types of cancer has not yet been adequately evaluated. METHODS We used publicly available databases of cancer incidence, cancer mortality and relative survival to… (More)
DOI: 10.1093/eurpub/ckq120


3 Figures and Tables